Down Syndrome And Dementia: A Randomized, Controlled Trial Of Antioxidant Supplementation
| Effect | None |
| Trial Design | Double blind |
| Trial Length | n/a |
| Number of Subjects | 53 |
| Sex | n/a |
Anti-oxidant therapy (600mg ALA, 200mg Vitamin C, 900 IU Vitamin E) in person's with Downs Syndrome over the age of 40 with the hypothesis of treating adult-onset Dementia. Trial was 2 years in length.
Anti-oxidant therapy was well-tolerated but ineffective.
